Searchable abstracts of presentations at key conferences in endocrinology

ea0050p265 | Neuroendocrinology and Pituitary | SFEBES2017

Is 11C-methionine PET co-registered with MRI a game changer for persistent acromegaly?

Bhatt Dhruti , Shyamasunder Asha Hesarghatta , Sifontes-Dubon Mildred , Straiton Jack , Olson Shona , Kamel Mahmoud , Graveling Alex , Philip Sam , Abraham Prakash

Aims: 11C-methionine positron emission tomography co-registered with MRI (met-PET/MRI) is a new imaging technique used for functioning pituitary adenomas. In patients with persistent acromegaly after primary therapy, met-PET/MRI can help identify the site(s) of residual pituitary adenoma when MRI appearances are inconclusive and direct further targeted intervention (Trans-sphenoidal surgery-TSS or radiotherapy).<p class="ab...

ea0050p265 | Neuroendocrinology and Pituitary | SFEBES2017

Is 11C-methionine PET co-registered with MRI a game changer for persistent acromegaly?

Bhatt Dhruti , Shyamasunder Asha Hesarghatta , Sifontes-Dubon Mildred , Straiton Jack , Olson Shona , Kamel Mahmoud , Graveling Alex , Philip Sam , Abraham Prakash

Aims: 11C-methionine positron emission tomography co-registered with MRI (met-PET/MRI) is a new imaging technique used for functioning pituitary adenomas. In patients with persistent acromegaly after primary therapy, met-PET/MRI can help identify the site(s) of residual pituitary adenoma when MRI appearances are inconclusive and direct further targeted intervention (Trans-sphenoidal surgery-TSS or radiotherapy).<p class="ab...

ea0094p237 | Neuroendocrinology and Pituitary | SFEBES2023

A post-operative fluid restriction protocol to reduce the incidence of delayed hyponatraemia following trans-sphenoidal pituitary surgery

Shyamasunder Asha Hesarghatta , Joseph Aneez , Kapoor Nitin , Paul Thomas , Thomas Nihal , Jebasingh Felix , Elizabeth Cherian Kripa , Rajan Remya , Prabhu Krishna , Chacko Ari , Christudoss Pamela , Jose Arun , Rebekah Grace

Delayed hyponatraemia(DH) is a well-known complication following trans-sphenoidal pituitary surgery (TSS), varying in incidence from 9–36% and occurs between post-operative days(POD) 4 to 14. Various studies have demonstrated that post-operative fluid restriction after TSS reduces the incidence of DH.Objective: to assess whether a fluid restriction protocol from POD5 to POD14 following TSS reduces the incidence of post-operative DH ...